Transcriptional ITPR3 As Potential Targets and Biomarkers for Human Pancreatic Cancer

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2022 May 17

PMID 35580861

Authors

Wangyang Zheng

Xue Bai

Yongxu Zhou

Liang Yu

Daolin Ji

Yuling Zheng

Nanfeng Meng

Hang Wang

Ziyue Huang

Wangming Chen

Judy Wai Ping Yam

Yi Xu

Yunfu Cui

Affiliations

Soon will be listed here.

Abstract

Inositol 1,4,5-Triphosphate Receptor Family (ITPRs) are necessary intracellular Ca2+-release channel encoders and participate in mammalian cell physiological and pathological processes. Previous studies have suggested that ITPRs participate in tumorigenesis of multiple cancers. Nevertheless, the diverse expression profiles and prognostic significance of three ITPRs in pancreatic cancer have yet to be uncovered. In this work, we examined the expression levels and survival dates of ITPRs in patients with pancreatic cancer. As a result, we identified that ITPR1 and ITPR3 expression levels are significantly elevated in cancerous specimens. Survival data revealed that over-expression of ITPR2 and ITPR3 resulted in unfavourable overall survival and pathological stage. The multivariate Cox logistic regression analysis showed that ITPR3 could be an independent risk factor for PAAD patient survival. Moreover, to investigate how ITPRs work, co-expressed genes, alterations, protein-protein interaction, immune infiltration, methylation, and functional enrichment of ITPRs were also analyzed. Then, we evaluated these findings in clinical samples. Moreover, the gain and loss of function of ITPR3 were also conducted. The electron microscope assay was employed to explore the role of ITPR3 in pancreatic cancer cell lines' endoplasmic reticulum stress. In summary, our findings demonstrated that ITPR3 has the potential to be drug targets and biomarkers for human pancreatic cancer.

Citing Articles

Breast cancer cells utilize T3 to trigger proliferation through cellular Ca modulation.

Tawfik I, Schlick K, Ostaku J, Bresilla D, Gabrijelcic S, Gottschalk B Cell Commun Signal. 2024; 22(1):533.

PMID: 39506805 PMC: 11539297. DOI: 10.1186/s12964-024-01917-y.

mRNA-seq-based analysis predicts: AEG-1 is a therapeutic target and immunotherapy biomarker for pan-cancer, including OSCC.

Yao L, Liu L, Xu W, Xi H, Lin S, Piao G Front Immunol. 2024; 15:1484226.

PMID: 39483471 PMC: 11524818. DOI: 10.3389/fimmu.2024.1484226.

Type 3 IP3 receptor: Its structure, functions, and related disease implications.

Wu L, Chen J Channels (Austin). 2023; 17(1):2267416.

PMID: 37818548 PMC: 10569359. DOI: 10.1080/19336950.2023.2267416.

Aberrations in ion channels interacting with lipid metabolism and epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

Parthasarathi K, Mandal S, George J, Gaikwad K, Sasidharan S, Gundimeda S Front Mol Biosci. 2023; 10:1201459.

PMID: 37529379 PMC: 10388552. DOI: 10.3389/fmolb.2023.1201459.

References

Ivanova H, Vervliet T, Missiaen L, Parys J, De Smedt H, Bultynck G . Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival. Biochim Biophys Acta. 2014; 1843(10):2164-83. DOI: 10.1016/j.bbamcr.2014.03.007. View

van de Leemput J, Chandran J, Knight M, Holtzclaw L, Scholz S, Cookson M . Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet. 2007; 3(6):e108. PMC: 1892049. DOI: 10.1371/journal.pgen.0030108. View

Liu Y, Tao S, Liao L, Li Y, Li H, Li Z . TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway. Nat Commun. 2020; 11(1):348. PMC: 6969153. DOI: 10.1038/s41467-019-14190-2. View

Ishikawa M, Yoshida K, Yamashita Y, Ota J, Takada S, Kisanuki H . Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells. Cancer Sci. 2005; 96(7):387-93. PMC: 11160054. DOI: 10.1111/j.1349-7006.2005.00064.x. View

Kerkhofs M, Seitaj B, Ivanova H, Monaco G, Bultynck G, Parys J . Pathophysiological consequences of isoform-specific IP receptor mutations. Biochim Biophys Acta Mol Cell Res. 2018; 1865(11 Pt B):1707-1717. DOI: 10.1016/j.bbamcr.2018.06.004. View

Prasad A, Rabionet R, Espinet B, Zapata L, Puiggros A, Melero C . Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome. J Invest Dermatol. 2016; 136(7):1490-1499. DOI: 10.1016/j.jid.2016.03.024. View

Zhang M, Wang L, Yue Y, Zhang L, Liu T, Jing M . ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-ĸB/CD44 pathway in urinary bladder carcinoma. J Exp Clin Cancer Res. 2021; 40(1):65. PMC: 7877014. DOI: 10.1186/s13046-021-01866-1. View

Ueasilamongkol P, Khamphaya T, Guerra M, Rodrigues M, Gomes D, Kong Y . Type 3 Inositol 1,4,5-Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma. Hepatology. 2019; 71(2):583-599. PMC: 6934938. DOI: 10.1002/hep.30839. View

Guerra M, Florentino R, Franca A, Lima Filho A, Dos Santos M, Fonseca R . Expression of the type 3 InsP receptor is a final common event in the development of hepatocellular carcinoma. Gut. 2019; 68(9):1676-1687. PMC: 7087395. DOI: 10.1136/gutjnl-2018-317811. View

10.

Zhao M, Wang J, Yuan M, Ma Z, Bao Y, Hui Z . Multivariate gene expression-based survival predictor model in esophageal adenocarcinoma. Thorac Cancer. 2020; 11(10):2896-2908. PMC: 7529573. DOI: 10.1111/1759-7714.13626. View

11.

Monteith G, Prevarskaya N, Roberts-Thomson S . The calcium-cancer signalling nexus. Nat Rev Cancer. 2017; 17(6):367-380. DOI: 10.1038/nrc.2017.18. View

12.

Keller S, Sanderson M, Stoeck A, Altevogt P . Exosomes: from biogenesis and secretion to biological function. Immunol Lett. 2006; 107(2):102-8. DOI: 10.1016/j.imlet.2006.09.005. View

13.

Behtaji S, Ghafouri-Fard S, Sayad A, Sattari A, Rederstorff M, Taheri M . Identification of oxytocin-related lncRNAs and assessment of their expression in breast cancer. Sci Rep. 2021; 11(1):6471. PMC: 7979916. DOI: 10.1038/s41598-021-86097-2. View

14.

Blando J, Sharma A, Higa M, Zhao H, Vence L, Yadav S . Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. Proc Natl Acad Sci U S A. 2019; 116(5):1692-1697. PMC: 6358697. DOI: 10.1073/pnas.1811067116. View

15.

Kamisawa T, Wood L, Itoi T, Takaori K . Pancreatic cancer. Lancet. 2016; 388(10039):73-85. DOI: 10.1016/S0140-6736(16)00141-0. View

16.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

17.

Tjensvoll K, Lapin M, Buhl T, Oltedal S, Steen-Ottosen Berry K, Gilje B . Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer. Mol Oncol. 2016; 10(4):635-43. PMC: 5423145. DOI: 10.1016/j.molonc.2015.11.012. View

18.

Messai Y, Noman M, Hasmim M, Escudier B, Chouaib S . HIF-2α/ITPR1 axis: A new saboteur of NK-mediated lysis. Oncoimmunology. 2015; 4(2):e985951. PMC: 4404821. DOI: 10.4161/2162402X.2014.985951. View

19.

van Es M, van Vught P, Blauw H, Franke L, Saris C, Andersen P . ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol. 2007; 6(10):869-77. DOI: 10.1016/S1474-4422(07)70222-3. View

20.

Fan L, Sun G, Ma T, Zhong F, Lei Y, Li X . Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing survivin. J Pineal Res. 2013; 55(2):184-94. DOI: 10.1111/jpi.12061. View